<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03073252</url>
  </required_header>
  <id_info>
    <org_study_id>1607017949</org_study_id>
    <nct_id>NCT03073252</nct_id>
  </id_info>
  <brief_title>The Acute Effect of Egg-Based High Protein Meal on Hypertensive Response to Exercise</brief_title>
  <acronym>S47</acronym>
  <official_title>The Acute Effect of Egg-Based High Protein Meal on Hypertensive Response to Exercise</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Purdue University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Purdue University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The primary purpose of this study is to explore the effect of high versus normal egg-based
      protein meals on acute exercise-induced elevated blood pressure.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      This study is designed to assess BP changes during and post- exercise after consumption of a
      test breakfast. The design consists of three visits. The first visit will assess each
      participants aerobic exercise capacity (VO2 max). Visit 2 and 3 will be clinical testing days
      where the subject will consume either the 13g or 30g protein breakfast in a randomized
      cross-over manner and perform the exercise intervention. BP changes will be monitored before
      and after breakfast consumption, during the exercise intervention,
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">January 1, 2017</start_date>
  <completion_date type="Actual">June 30, 2017</completion_date>
  <primary_completion_date type="Actual">June 30, 2017</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Crossover Assignment</intervention_model>
    <intervention_model_description>subject will consume either the 13g or 30g protein breakfast in a randomized cross-over manner</intervention_model_description>
    <primary_purpose>Diagnostic</primary_purpose>
    <masking>Triple (Participant, Investigator, Outcomes Assessor)</masking>
    <masking_description>Care provider will randomize participants and keep the participant, investigator and outcomes assessor blinded to the randomization.</masking_description>
  </study_design_info>
  <primary_outcome>
    <measure>Blood Pressure Changes</measure>
    <time_frame>6hr testing</time_frame>
    <description>Changes from Baseline to Post Systolic Blood Pressure during 30 minute exercise session</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Vasoactive Molecules</measure>
    <time_frame>6 hrs</time_frame>
    <description>Vasoactive Molecules analysis using plasma</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">31</enrollment>
  <condition>Blood Pressure</condition>
  <condition>Cardiovascular Risk Factor</condition>
  <arm_group>
    <arm_group_label>Normal Protein</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Consumption of normal protein (NP) meal</description>
  </arm_group>
  <arm_group>
    <arm_group_label>High Protein</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Consumption of high protein (HP) meal</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Normal Protein</intervention_name>
    <description>Consumption of a normal protein (NP), egg-based (13 g protein; whole eggs) breakfast bowl</description>
    <arm_group_label>Normal Protein</arm_group_label>
    <arm_group_label>High Protein</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>HIgh Protein</intervention_name>
    <description>Consumption of a high protein (HP), egg-based (30 g protein; whole eggs) breakfast bowl</description>
    <arm_group_label>Normal Protein</arm_group_label>
    <arm_group_label>High Protein</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Pre-hypertensive (systolic, 120-139 mm Hg; diastolic, 80-89 mm Hg

          -  Age ≥ 21

          -  Body weight &lt;300 lb (136 kg)

          -  BMI between 20 and 34.9 kg/m2

          -  Fasting plasma glucose &lt;6.1 mmol/L,

          -  total cholesterol &lt;6.7 mmol/L

          -  LDL cholesterol &lt;4.1 mmol/L

          -  TG &lt;4.5 mmol/L

          -  No pre-existing or history of cardiovascular, renal or liver disease

          -  Not currently or previously (past 6 mo) consuming a weight-loss diet or other
             special/non-balanced diets

          -  No weight loss/gain (±4.5 kg) within the past 6 mo

          -  No physical impairments preventing properly exercise execution

          -  No caffeine intake the day of testing

        Exclusion Criteria:

          -  Hypertensive

          -  Body weight ≥ 300 lb

          -  BMI &lt;20 or &gt;35 kg/m2

          -  Pregnant or planning pregnancy

          -  Unwilling to consume study foods and beverages

          -  Fasting plasma glucose ≥6.1 mmol/L

          -  Total cholesterol ≥6.7 mmol/L

          -  LDL cholesterol ≥4.1 mmol/L

          -  TG ≥4.5 mmol/L

          -  acute illness

          -  smoking

          -  diabetic

          -  pre-existing or history of cardiovascular, renal or liver disease

          -  currently or previously (past 6 mo) consuming a weight-loss diet or other
             special/non-balanced diets

          -  weight loss/gain (±4.5 kg) within the past 6 months

          -  physical impairments preventing properly exercise execution

          -  caffeine the day of testing
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>21 Years</minimum_age>
    <maximum_age>121 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Purdue University</name>
      <address>
        <city>West Lafayette</city>
        <state>Indiana</state>
        <zip>47907</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>January 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>February 14, 2017</study_first_submitted>
  <study_first_submitted_qc>March 2, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">March 8, 2017</study_first_posted>
  <last_update_submitted>January 9, 2018</last_update_submitted>
  <last_update_submitted_qc>January 9, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">January 12, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Purdue University</investigator_affiliation>
    <investigator_full_name>Wayne Campbell</investigator_full_name>
    <investigator_title>Principal Investigator</investigator_title>
  </responsible_party>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
    <ipd_description>no plans to share data with other researchers</ipd_description>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

